Pressure ulcer of left lower back, stage 1
ICD-10 L89.141 is a billable code used to indicate a diagnosis of pressure ulcer of left lower back, stage 1.
L89.141 refers to a stage 1 pressure ulcer located on the left lower back. Clinically, a stage 1 pressure ulcer is characterized by non-blanchable erythema of intact skin, indicating localized redness that does not fade when pressure is applied. This condition arises from prolonged pressure on the skin, often due to immobility or inadequate repositioning in patients, particularly those with limited mobility or chronic illnesses. The left lower back area is anatomically significant as it is a common site for pressure ulcers due to the bony prominence of the sacrum and the weight of the body when seated or lying down. Disease progression can lead to more severe stages of pressure ulcers if not properly managed, potentially resulting in skin breakdown and infection. Diagnostic considerations include a thorough skin assessment, patient history, and risk assessment tools such as the Braden Scale. Early identification and intervention are crucial to prevent further deterioration of the ulcer and associated complications.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L89.141 specifically covers stage 1 pressure ulcers located on the left lower back. It indicates the initial stage of skin breakdown due to pressure, characterized by non-blanchable erythema without skin loss.
L89.141 should be used when documenting a stage 1 pressure ulcer on the left lower back. It is important to differentiate it from other stages (L89.142 for stage 2, etc.) and from ulcers located on different body parts.
Documentation should include a detailed assessment of the ulcer, including its size, appearance, and any interventions taken. Risk assessment tools, patient history, and ongoing treatment plans should also be documented to support the coding.
